Senzime Launches New Sustainable TetraSens EMG Sensor
UPPSALA, Sweden, June 1, 2026 Senzime AB announced the commercial launch of its next-generation TetraSens® electromyography (EMG) sensor, designed...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
UPPSALA, Sweden, June 1, 2026 Senzime AB announced the commercial launch of its next-generation TetraSens® electromyography (EMG) sensor, designed...
UPPSALA, Sweden, May 27, 2026 Senzime AB announced that the U.S. Food and Drug Administration has granted an additional...
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
Amsterdam, Netherlands – April 23, 2026 Philips announced the launch of its next-generation Bridge Plus Occlusion Balloon, a life-saving...
PITTSBURGH, Pa., April 17, 2026 Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k)...
MISSISSAUGA, Ontario, Feb. 19, 2026 — Covalon Technologies Ltd. announced a strategic educational collaboration with the Association for Vascular...
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 Retia Medical has received U.S. FDA 510(k) clearance for...
Ottawa, Canada — February 6, 2026 Health authorities have issued a public advisory announcing the recall of two lots...
NAPA, Calif., February 3, 2026 — The Doctors Company, the largest physician-owned medical malpractice insurer in the United States,...
September 18, 2025 — Caesarea, Israel IceCure has been granted a Notice of Allowance by the U.S. Patent and...
